5-APB
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| PsychonautWiki | TripSit | Pharmacology | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | ≈ | ||
| Also known as | 5-APB | 5apb | — | = |
| Safety | ||||
| Addiction potential | moderately addictive with a high potential for abuse | — | — | |
| Toxicity | exact toxic dosage is unknown | — | — | |
| Dangerous interactions | — | — | ||
| Unsafe interactions | — | — | ||
| Dose · Oral | ||||
| Threshold | 20 mg | — | — | |
| Light | 40–60 mg | 40–60 mg | — | = |
| Common | 60–80 mg | 70–100 mg | — | ≠ |
| Strong | 80–100 mg | — | — | |
| Heavy | 100 mg+ | — | — | |
| Duration | ||||
| Onset | 20–60 minutes | 45 minutes | — | ≠ |
| Total | 5–8 hours | 7–8 hours | — | ≠ |
| After-effects | 6–48 hours | — | — | |
| Pharmacology | ||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
PsychonautWiki oral
TripSit Oral
0125 mg
LightCommonStrongHeavy
Duration at a glance
Total duration on one shared scale.
PsychonautWiki
TripSit
TripSit summary
A triple monoamine reuptake inhibitor. This agonism for 5-HT2B makes it likely that 5-APB would be cardiotoxic with long term use, as seen in other 5-HT2B agonists such as fenfluramine and MDMA.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.